… to two drugs, a test must distinguish drug-induced … treatment and from the errors of the
measurement itself. In the present study, the FEV 1 was found to be superior to the other five tests …

… therefore tested the ability of acute change in forced expired volume in one second (FEV
1 ) following inhaled beta agonist to predict long-term symptomatic response to albuterol and …

… the ability of bronchodilator testing to differentiate between … or in the selection of patients
for inclusion in treatment trials. … in FEV 1 controlled for the post-bronchodilator FEV 1 value …

… We tested the hypothesis that long-term treatment directed at both bronchodilation and …
agent), which may in turn be superior to treatment with a single agent (β 2 -agonist alone). …

… residual effects of previous bronchodilator therapy) 1, as well as … the best opportunity for
determining optimal bronchodilator … methodologically optimised bronchodilator testing, as in the …

… When evaluating a single bronchodilator, we demand … for combination therapies has not
been specifically tested. … the most optimum combination bronchodilator therapy for our patients, …

… The first day of testing was a control day with hourly testing as noted from 9 AM to 1 PM. …
The tests were then repeated hourly from 9 AM to 1 PM as on the control day. The sequence …

… report entitled "The One Best Test for Evaluating the Effects of Bronchodilator Therapy" by
Light … One cannot say that the persistence of the effects of a drug at 300 minutes represents an …

… groups for future treatment trials. To test this, we have conducted a single blind randomised
… breathing pattern after single and combination bronchodilator treatment, respectively. Mean …

… therapy involving two long-acting bronchodilators with … is not sufficiently controlled with
monotherapy (Table 1) [9]. The … The rationale for improved bronchodilation has been tested in …